DOCSLIB.ORG

Regulation of Autophagy by Acetyl Coenzime a : from the Mechanisms to a Revised Definition of Caloric Restriction Mimetics Federico Pietrocola

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Regulation of Autophagy by Acetyl Coenzime a : from the Mechanisms to a Revised Definition of Caloric Restriction Mimetics Federico Pietrocola Regulation of Autophagy by Acetyl Coenzime A : From the Mechanisms to a Revised Definition of Caloric Restriction Mimetics Federico Pietrocola To cite this version: Federico Pietrocola. Regulation of Autophagy by Acetyl Coenzime A : From the Mechanisms to a Revised Definition of Caloric Restriction Mimetics. Cellular Biology. Université Paris Sud -ParisXI, 2015. English. NNT : 2015PA11T039. tel-01580849 HAL Id: tel-01580849 https://tel.archives-ouvertes.fr/tel-01580849 Submitted on 3 Sep 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITE PARIS SUD ÉCOLE DOCTORALE 418 DE CANCÉROLOGIE Laboratoire : UMR1138 Apoptosis, Cancer & Immunity THESE Présentée et soutenue publiquement par FEDERICO PIETROCOLA Le 2 septembre 2015 REGULATION OF AUTOPHAGY BY ACETYL COENZIME A: FROM THE MECHANISMS TO A REVISED DEFINITION OF CALORIC RESTRICTION MIMETICS Composition du jury Directeur de thèse Pr. Guido KROEMER Directeur de Recherche UMR1138 (CRC Paris) Rapporteur Pr. Pascal FERRE Directeur CRC (CRC Paris) Dr. Patricia BOYA Directeur de Laboratoire (CIB-CSIC- Madrid) Examinateur Pr. Jose M. FUENTES Directeur de Laboratoire (UNEX RODRIGUEZ Caceres) Pr. Laurence ZITVOGEL Directeur de Recherche UMR1015 (IGR Villejuif) Dr. Maria Chiara MAIURI Chargé de Recherche UMR1138 (CRC Paris) INDEX ABBREVIATIONS ........................................................................................................................................ 2 I. SUMMARY ........................................................................................................................................... 11 II. INTRODUCTION .............................................................................................................................. 14 A. GENERAL PRINCIPLES OF THE AUTOPHAGIC PATHWAYS ........................................................... 14 B. MECHANISMS AND REGULATION OF AUTOPHAGOSOME FORMATION ................................. 16 C. HOUSEKEEPING FUNCTIONS OF AUTOPHAGY ................................................................................... 26 D. AUTOPHAGIC RESPONSE TO METABOLIC STRESS: THE CROSS-TALK BETWEEN AUTOPHAGY AND METABOLISM ....................................................................................................................... 29 1. Energy Charge/ Glucose deprivation ........................................................................................................ 30 2. Hypoxia and ROS .............................................................................................................................................. 32 3. NADH/NAD Ratio ............................................................................................................................................. 33 4. Response to amino acids starvation ........................................................................................................... 35 5. Lipids ...................................................................................................................................................................... 38 6. Sensing of micronutrients: depletion of iron .......................................................................................... 40 7. Metabolic byproducts: Ammonia ................................................................................................................ 40 8. Transcription Factors, Metabolism and Autophagy ............................................................................ 40 9. Metabolic Regulation of Autophagy in vivo ............................................................................................ 42 E. ROLE OF AUTOPHAGY IN THE PATHOGENESIS OF DISEASE ........................................................ 45 1. Autophagy and Cancer .................................................................................................................................... 46 2. Autophagy in metabolic disease .................................................................................................................. 52 3. AUTOPHAGY AND AGING ......................................................................................................................... 55 III. AIM OF THE WORK ..................................................................................................................... 57 IV. RESULTS ........................................................................................................................................... 70 V. MATERIALS AND METHODS ..................................................................................................... 72 VI. DISCUSSION .................................................................................................................................... 90 VII. REFERENCES .............................................................................................................................. 107 1 ABBREVIATIONS 2-DG = 2-DeoxyGlucose 4EBP1 = Eukaryotic translation initiation factor 4E Binding Protein 1 ACAC = Acetyl CoA Carboxylase AcCoA = AcetylCoA ACLY = ATP Citrate Lyase ACO1 = Aconitase 1 ACSS = Acyl-CoA Synthetase Short-chain family Akt = v-Akt murine thymoma viral oncogene homolog 1 ALDH = Aldehyde Dehydrogenase AMBRA1 = Activating Molecule in BECN-1 Regulated Autophagy protein 1 AMP = Adenosine MonoPhosphate AMPK = Adenosine MonoPhosphate-activated Protein Kinase APP = Aβ-extracellular amyloid plaques derived from Amyloid Precursor Protein ATF4 = Activating Transcription Factor 4 ATG = Autophagy related 2 ATP = Adenosine TriPhosphate Bak = BCL2-antagonist/killer Bax = BCL2-associated X protein BCAA = Branched-Chain Amino Acids BCAT1 = Branched-Chain amino Acid Transaminase 1 BCKD = Branched-Chain α-Ketoacid Dehydrogenase Bcl-2 = member B-cell lymphoma 2 BDH1 = 3-HydroxyButyrate Dehydrogenase, type 1 BECN1 = Beclin-1 BNIP3 = BCL2/adenovirus E1B 19kDa interacting Protein 3-like JNK1 = c-Jun N-terminal Kinase 1 CAMMK2 = Calcium/calmodulin-dependent protein Kinase 2 CLEAR = Coordinate Lysosome Expression And Regulation CMA = Chaperone Mediated Autophagy CNS = Central Nervous System CoA = Coenzyme A 3 CPT1 = Carnitine PalmitoylTransferase 1 CR = Caloric Restriction CRAT = Carnitine O-AcetylTransferase CRM = Caloric Restriction Mimetics CS = Citrate Synthase DAMP = Damage-Associated Molecular Pattern molecules DCA = Dichloroacetate DEPTOR = DEP domanin containing MTOR-interacting protein DFCP1 = Double FYVE Containing Protein 1 DLAT = DihydroLipoamide S-AcetylTransferase DLD = DihydroLipoamide Dehydrogenase DR = Dietary Restriction EGFR = Epithelial Growth Factor Receptor EIF2AK3 = Eukaryotic translation Initiation Factor 2-Alpha Kinase 3 eIF2α = eukaryotic translation Initiation Factor 2 alpha ER = Endoplasmic Reticulum 4 ERGIC = ER-Golgi Intermediate Compartment FIP200 = FAK family kinase activating protein of 200 kDa FOXO1 = Forkhead box O1 GAAC = General Amino Acids Control GAG = Glycosaminoglycans GAP = Guanosine triphosphatase Activating Protein GATOR = GAP activity towards Rag GFP = Green Fluorescent Protein GH = Growth Hormone GLS = Glutaminase GOT2 = Glutamic-Oxaloacetic Transaminase 2 GTP = Guanosine TriPhosphate HSC70 = Heat Shock Cognate 70 HDAC = Histone Deacetylases HFD = High Fat Diet HIF1-α = Hypoxia Inducible Factor 1-alpha 5 HAT = Histone AcetylTransferases HK-II = Hexokinase-II HPV = Human Papilloma Virus ICD = Immunogenic Cell Death IDH1 = Isocitrate Dehydrogenase 1 IGF-1 = Insulin Growth Factor -1 IGFBP = Insulin-like Growth Factor Binding Protein Ikkβ = Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta I IL = Interleukin KAT = Lysine acetyltransferases Keap1 = Kelch-like ECH-associated protein 1 LAMP-2A = Lysosome-Associated Membrane Protein 2 ESCRT = Endosomal Sorting Complex Required for Transport LIR = LC3 Interacting LKB1 = Liver Kinase B1 LRRK2 = Leucine-Rich Repeat Kinase 2 6 MAM = Mitochondria-Associated Membrane MAPK = Mitogen-Activated Protein Kinase MDH1 = Malate Dehydrogenase 1 ME = Malic Enzyme MEF = Mouse Embryo Fibroblast mETC = mitochondrial Electron Transport Chain MPC = Mitochondrial Pyruvate Carrier mTORC1 = mammalian Target Of Rapamycin Complex 1 MVB = Multivescicolar Body NAD = Nicotinamide Dinucleotide NADH = Nicotinamide Adenine Dinucleotide NADP = Nicotinamide Dinucleotide Phosphate NAMPT = Nicotinamide Phosphoribosyltransferase NBR1 = Neighbor of BRCA1 gene 1 Nrf2 = Nuclear Factor, Erythroid 2-Like 2 OIS = Oncogene Induced Senescence 7 OXCT1 = 3-Oxoacid CoA Transferase 1 OXPHOS = Oxidative Phosphorylation PAMP = Pathogen-Associated Molecular Patterns PDH = Pyruvate Dehydrogenase PDHX = Pyruvate Dehydrogenase complex, component X PDK = Pyruvate Dehydrogenase Kinase PDP = Pyruvate Dehydrogenase Phosphatase PE = PhosphatidylEthanolamine PGC-1α = Proliferator-activated receptor Gamma Coactivator 1-alpha PI3KIII = Class III Phosphatidylinositol-3 Kinase PINK1 = PTEN Induced putative Kinase 1 PKD = Protein Kinase D PNPLA5 = Patatin-like phospholipase domain containing 5 PRAS40 = Proline-Rich
Load more

Recommended publications
  • Global Proteomics Analysis of the Response to Starvation in C. Elegans*DS
    Research Author’s Choice © 2015 by The American Society for Biochemistry and Molecular Biology, Inc. This paper is available on line at http://www.mcponline.org Global Proteomics Analysis of the Response to Starvation in C. elegans*□S Mark Larance‡¶, Ehsan Pourkarimi‡¶, Bin Wang‡, Alejandro Brenes Murillo, Robert Kent, Angus I. Lamond‡§, and Anton Gartner‡§ Periodic starvation of animals induces large shifts in me- ment, however, requires feeding and progresses through four tabolism but may also influence many other cellular sys- developmental stages (L1-L4). The effect of starvation varies tems and can lead to adaption to prolonged starvation at these different developmental stages. Hatching of L1 stage conditions. To date, there is limited understanding of larvae in the absence of food leads to a starvation response how starvation affects gene expression, particularly at without overt morphogenesis that allows for ϳ2 weeks of the protein level. Here, we have used mass-spectro- survival (2). Mid- and late-stage L4 larvae, upon starvation, metry-based quantitative proteomics to identify global develop into adults but preserve resources by reducing germ changes in the Caenorhabditis elegans proteome due to cell proliferation and thereby holding a limited number of acute starvation of young adult animals. Measuring changes in the abundance of over 5,000 proteins, we embryos (3, 4). show that acute starvation rapidly alters the levels of Conserved genetic pathways have been identified that link hundreds of proteins, many involved in central metabolic nutrient availability to metabolic remodeling, stress resistance pathways, highlighting key regulatory responses. Surpris- pathways, and enhanced life span. Many of these pathways ingly, we also detect changes in the abundance of chro- overlap and include TOR, AMPK, autophagy, and insulin/ matin-associated proteins, including specific linker his- IGF-1 signaling.
    [Show full text]
  • A Turkish Patient with Succinyl-Coa:3-Oxoacid Coa
    Original Article Journal of Inborn Errors of Metabolism & Screening 2016, Volume 4: 1–5 A Turkish Patient With ª The Author(s) 2016 DOI: 10.1177/2326409816651281 Succinyl-CoA:3-Oxoacid CoA iem.sagepub.com Transferase Deficiency Mimicking Diabetic Ketoacidosis Sahin Erdol, MD1, Mehmet Ture, MD2, Tahsin Yakut, PhD2, Halil Saglam, PhD1, Hideo Sasai, MD3, Elsayed Abdelkreem, MD3, Hiroki Otsuka, MD3, and Toshiyuki Fukao, MD, PhD3 Abstract Succinyl-CoA:3-oxoacid CoA transferase (SCOT) deficiency is an autosomal recessive disorder of ketone body utilization that is clinically characterized with intermittent ketoacidosis crises. We report here the second Turkish case with SCOT deficiency. She experienced 3 ketoacidotic episodes: The first ketoacidotic crisis mimicked diabetic ketoacidosis because of the associated hyperglycemia. Among patients with SCOT deficiency, the blood glucose levels at the first crises were variable, and this case had the highest ever reported blood glucose level. She is a compound heterozygote with 2 novel mutations, c.517A>G (K173E) and c.1543A>G (M515V), in exons 5 and 17 of the OXCT1 gene, respectively. In patient’s fibroblasts, SCOT activity was deficient and, by immunoblot analysis, SCOT protein was much reduced. The patient attained normal development and had no permanent ketosis. The accurate diagnosis of SCOT deficiency in this case had a vital impact on the management strategy and outcome. Keywords succinyl-CoA:3-oxoacid CoA transferase, deficiency, mimicking, diabetic ketoacidosis, Turkey Introduction deficiency. We herein describe a Turkish SCOT-deficient patient whose first episode mimicked diabetic ketoacidosis Succinyl-CoA:3-oxoacid CoA transferase (SCOT) deficiency because of the associated hyperglycemia.
    [Show full text]
  • Atg4b Antibody A
    Revision 1 C 0 2 - t Atg4B Antibody a e r o t S Orders: 877-616-CELL (2355) [email protected] Support: 877-678-TECH (8324) 9 9 Web: [email protected] 2 www.cellsignal.com 5 # 3 Trask Lane Danvers Massachusetts 01923 USA For Research Use Only. Not For Use In Diagnostic Procedures. Applications: Reactivity: Sensitivity: MW (kDa): Source: UniProt ID: Entrez-Gene Id: WB H M R Endogenous 48 Rabbit Q9Y4P1 23192 Product Usage Information 2. Ohsumi, Y. (2001) Nat Rev Mol Cell Biol 2, 211-6. 3. Kabeya, Y. et al. (2000) EMBO J 19, 5720-8. Application Dilution 4. Kabeya, Y. et al. (2004) J Cell Sci 117, 2805-12. 5. Mariño, G. et al. (2003) J Biol Chem 278, 3671-8. Western Blotting 1:1000 6. Sou, Y.S. et al. (2008) Mol Biol Cell 19, 4762-75. 7. Hemelaar, J. et al. (2003) J Biol Chem 278, 51841-50. Storage 8. Kabeya, Y. et al. (2004) J Cell Sci 117, 2805-12. 9. Tanida, I. et al. (2004) J Biol Chem 279, 36268-76. Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% 10. Fujita, N. et al. (2008) Mol Biol Cell 19, 4651-9. glycerol. Store at –20°C. Do not aliquot the antibody. 11. Fujita, N. et al. (2009) Autophagy 5, 88-9. Specificity / Sensitivity Atg4B Antibody detects endogenous levels of total Atg4B protein. This antibody detects a band at ~27 kDa of unknown origin. Species Reactivity: Human, Mouse, Rat Source / Purification Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Ser372 of human Atg4B protein.
    [Show full text]
  • Phosphatidylethanolamine Positively Regulates Autophagy and Longevity
    Cell Death and Differentiation (2015) 22, 499–508 OPEN & 2015 Macmillan Publishers Limited All rights reserved 1350-9047/15 www.nature.com/cdd Phosphatidylethanolamine positively regulates autophagy and longevity P Rockenfeller1, M Koska1, F Pietrocola2, N Minois3, O Knittelfelder1, V Sica2, J Franz1, D Carmona-Gutierrez1, G Kroemer*,2,4,5,6,7 and F Madeo*,1,8 Autophagy is a cellular recycling program that retards ageing by efficiently eliminating damaged and potentially harmful organelles and intracellular protein aggregates. Here, we show that the abundance of phosphatidylethanolamine (PE) positively regulates autophagy. Reduction of intracellular PE levels by knocking out either of the two yeast phosphatidylserine decarboxylases (PSD) accelerated chronological ageing-associated production of reactive oxygen species and death. Conversely, the artificial increase of intracellular PE levels, by provision of its precursor ethanolamine or by overexpression of the PE-generating enzyme Psd1, significantly increased autophagic flux, both in yeast and in mammalian cell culture. Importantly administration of ethanolamine was sufficient to extend the lifespan of yeast (Saccharomyces cerevisiae), mammalian cells (U2OS, H4) and flies (Drosophila melanogaster). We thus postulate that the availability of PE may constitute a bottleneck for functional autophagy and that organismal life or healthspan could be positively influenced by the consumption of ethanolamine-rich food. Cell Death and Differentiation (2015) 22, 499–508; doi:10.1038/cdd.2014.219; published online 9 January 2015 Phosphatidylethanolamine (PE) is a phospholipid found in all linked to ageing. Autophagy mainly differs from the proteaso- living organisms. Together with phosphatidylcholine (PC), mal pathway, the other major cellular degradation mechanism, phosphatidylserine (PS) and phosphatidylinositol (PI), PE in two aspects.
    [Show full text]
  • Novel Compound Heterozygous OXCT1 Mutations Causing Succinyl-Coa:3-Ketoacid Coa Transferase Deficiency
    Case Report Yonsei Med J 2019 Mar;60(3):308-311 https://doi.org/10.3349/ymj.2019.60.3.308 pISSN: 0513-5796 · eISSN: 1976-2437 A Rare Cause of Life-Threatening Ketoacidosis: Novel Compound Heterozygous OXCT1 Mutations Causing Succinyl-CoA:3-Ketoacid CoA Transferase Deficiency Young A Kim1,2, Seong Heon Kim1, Chong Kun Cheon1, and Yoo-Mi Kim3 1Department of Pediatrics, Pusan National University Children’s Hospital, Yangsan; 2Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan; 3Department of Pediatrics, Chungnam National University Hospital, College of Medicine, Chungnam National University, Daejeon, Korea. Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency is a rare inborn error of ketone body utilization, characterized by ep- isodic or permanent ketosis. SCOT deficiency is caused by mutations in the OXCT1 gene, which is mapped to 5p13 and consists of 17 exons. A 12-month-old girl presented with severe ketoacidosis and was treated with continuous renal replacement therapy. She had two previously unrecognized mild-form episodes of ketoacidosis followed by febrile illness. While high levels of ketone bodies were found in her blood and urine, other laboratory investigations, including serum glucose, were unremarkable. We identified novel compound heterozygous mutations in OXCT1:c.1118T>G (p.Ile373Ser) and a large deletion ranging from exon 8 to 16 through targeted exome sequencing and microarray analysis. This is the first Korean case of SCOT deficiency caused by novel mutations in OXCT1, resulting in life-threatening ketoacidosis. In patients with unexplained episodic ketosis, or high anion gap metabolic acidosis in infancy, an inherited disorder in ketone body metabolism should be suspected.
    [Show full text]
  • Cysteine Proteases in Protozoan Parasites
    UC San Diego UC San Diego Previously Published Works Title Cysteine proteases in protozoan parasites. Permalink https://escholarship.org/uc/item/6sb6c27b Journal PLoS neglected tropical diseases, 12(8) ISSN 1935-2727 Authors Siqueira-Neto, Jair L Debnath, Anjan McCall, Laura-Isobel et al. Publication Date 2018-08-23 DOI 10.1371/journal.pntd.0006512 Peer reviewed eScholarship.org Powered by the California Digital Library University of California REVIEW Cysteine proteases in protozoan parasites Jair L. Siqueira-Neto1*, Anjan Debnath1, Laura-Isobel McCall1¤, Jean A. Bernatchez1, Momar Ndao2,3, Sharon L. Reed4, Philip J. Rosenthal5 1 Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America, 2 National Reference Centre for Parasitology, The Research Institute of the McGill University Health Center, Montreal, Canada, 3 Program in Infectious Diseases and Immunity in Global Health, The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada, 4 Departments of Pathology and Medicine, University of California San Diego School of Medicine, La Jolla, California, United States of America, 5 Department of Medicine, University of California, San Francisco, San Francisco, California, a1111111111 United States of America a1111111111 a1111111111 ¤ Current address: Department of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma, a1111111111 United States of America a1111111111 * [email protected] Abstract OPEN ACCESS Cysteine proteases (CPs) play key roles in the pathogenesis of protozoan parasites, includ- Citation: Siqueira-Neto JL, Debnath A, McCall L-I, ing cell/tissue penetration, hydrolysis of host or parasite proteins, autophagy, and evasion Bernatchez JA, Ndao M, Reed SL, et al.
    [Show full text]
  • Transcriptomic Analysis Reveals Niche Gene Expression Effects of Beta
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.19.427259; this version posted January 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Transcriptomic analysis reveals niche gene expression effects of beta- hydroxybutyrate in primary myotubes Philip M. M. Ruppert1, Guido J. E. J. Hooiveld1, Roland W. J. Hangelbroek1,2, Anja Zeigerer3,4, Sander Kersten1,$ 1Nutrition, Metabolism and Genomics Group, Division of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands; 2Euretos B.V., Utrecht, The Netherlands 3Institute for Diabetes and Cancer, Helmholtz Center Munich, 85764 Neuherberg, Germany, Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Heidelberg, Germany; 4German Center for Diabetes Research (DZD), 85764 Neuherberg, Germany $ To whom correspondence should be addressed: Sander Kersten, PhD Division of Human Nutrition and Health Wageningen University Stippeneng 4 6708 WE Wageningen The Netherlands Phone: +31 317 485787 Email: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2021.01.19.427259; this version posted January 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abbreviations: βOHB β-hydroxybutyrate AcAc acetoacetate Kbhb lysine β-hydroxybutyrylation HDAC histone deacetylase bioRxiv preprint doi: https://doi.org/10.1101/2021.01.19.427259; this version posted January 20, 2021.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • A Glucose-Starvation Response Regulates the Diffusion of Macromolecules Ryan P
    A glucose-starvation response regulates the diffusion of macromolecules Ryan P. Joyner, Jeffrey H. Tang, Jonne Helenius, Elisa Dultz, Christiane Brune, Liam J. Holt, Sébastien Huet, Daniel J. Müller, Karsten Weis To cite this version: Ryan P. Joyner, Jeffrey H. Tang, Jonne Helenius, Elisa Dultz, Christiane Brune, et al.. Aglucose- starvation response regulates the diffusion of macromolecules. eLife, eLife Sciences Publication, 2016, 5, pp.e09376. 10.7554/eLife.09376. hal-01295659 HAL Id: hal-01295659 https://hal-univ-rennes1.archives-ouvertes.fr/hal-01295659 Submitted on 4 Oct 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. RESEARCH ARTICLE A glucose-starvation response regulates the diffusion of macromolecules Ryan P Joyner1, Jeffrey H Tang2, Jonne Helenius3, Elisa Dultz1†, Christiane Brune1, Liam J Holt4, Sebastien Huet5, Daniel J Mu¨ ller3, Karsten Weis1,2* 1Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States; 2Institute of Biochemistry, Department of Biology, ETH Zurich, Zu¨ rich, Switzerland; 3Department of Biosystems Science and Engineering, ETH Zurich, Zu¨ rich, Switzerland; 4Institute for Systems Genetics, New York University School of Medicine, New York, United States; 5CNRS, UMR 6290, Institut Ge´ne´tique et De´veloppement, University of Rennes, Rennes, France Abstract The organization and biophysical properties of the cytosol implicitly govern molecular interactions within cells.
    [Show full text]
  • DATASHEET USA: [email protected]
    DATASHEET USA: [email protected] FOR IN VITRO RESEARCH USE ONLY Europe: [email protected] NOT FOR USE IN HUMANS OR ANIMALS China: [email protected] OXCT1 Polyclonal Anbody Catalog number: 12175-1-AP Background Size: 38 μg/150 μl 3-oxoacid-CoA transferase 1 (OXCT1), encoded by nuclear gene, is a mitochondrial Source: Rabbit CoA transferase required for ketone body degradaon. It catalyzes the transfer of Isotype: IgG CoA from succinyl-CoA to acetoacetate, generang acetoacetyl-CoA. OXCT1 is Synonyms: expressed in brain, heart, and skeletal muscle, but not in liver. This anbody OXCT1; 3 oxoacid CoA specifically recognizes endogenous OXCT1. (21209089) transferase 1, OXCT, OXCT1, SCOT, SCOT s Applications Tested applicaons: ELISA, WB, IHC, IF, IP Cited applicaons: IHC, WB Species specificity: Human,Mouse,Rat; other species not tested. Cited species: Human, mouse Caculated OXCT1 MW: 520aa,56 kDa Observed OXCT1 MW: 56 kDa Posive WB detected in Human brain ssue, human heart ssue, human kidney Immunofluorescent analysis of MCF-7 ssue, human lung ssue, mouse skeletal muscle ssue, cells, using OXCT1 anbody 12175-1- AP at 1:25 diluon and Rhodamine- mouse thymus ssue labeled goat an-rabbit IgG (red). Posive IP detected in Mouse brain ssue Posive IHC detected in Human medulloblastoma ssue Posive IF detected in MCF-7 cells Recommended diluon: WB: 1:1000-1:10000 IP: 1:500-1:5000 IHC: 1:20-1:200 IF: 1:10-1:100 Applicaon key: WB = Western blong, IHC = Immunohistochemistry, IF = Immunofluorescence, IP = Immunoprecipitaon Immunohistochemical of paraffin- embedded human medulloblastoma Immunogen information using 12175-1-AP(SCOT anbody) at diluon of 1:50 (under 10x lens) Immunogen: Ag2818 GenBank accession number: BC009001 Gene ID (NCBI): 5019 Full name: 3-oxoacid CoA transferase 1 Product information Purificaon method: Angen affinity purificaon Storage: PBS with 0.1% sodium azide and 50% glycerol pH o human brain ssue were subjected to 7.3.
    [Show full text]
  • Ricardaâ•Žs Doktorarbeit
    Insights into membrane binding of PROPPINs and Reconstitution of mammalian autophagic conjugation systems Dissertation for the award of the degree "Doctor rerum naturalium" (Dr. rer. nat.) of the Georg-August-Universität Göttingen in the GGNB program of Biomolecules: Structure - Function - Dynamics of the Georg-August University School of Science (GAUSS) submitted by Ricarda Angela Busse from Leinefelde, now Leinefelde-Worbis, Germany Göttingen, 2012 Members of the Thesis Committee: Dr. Karin Kühnel (1st Reviewer) Department of Neurobiology, Max Planck Institute for Biophysical Chemistry Prof. Dr. Michael Thumm (2nd Reviewer) Department of Biochemistry II, University of Göttingen Prof. Dr. Nils Brose Department of Molecular Neurobiology, Max Planck Institute for Experimental Medicine Date of the oral examination: January 08th, 2013 Declaration of Authorship Declaration of Authorship Hereby, I confirm that I have created this work Insights into membrane binding of PROPPINs and Reconstitution of mammalian autophagic conjugation systems entirely on my own and that I have only used the sources and materials cited. Göttingen, November 14th, 2012 Ricarda Angela Busse V VI VII For Patrick Acknowledgements First and foremost I would like to thank my advisor Dr. Karin Kühnel for giving me the opportunity to do the research in her lab. Without her supervision and training this thesis would not have been possible. Her door was always open for questions and discussions. Moreover, I would like to thank Prof. Dr. Reinhard Jahn for offering the generous financial support during my thesis and for the regular discussions we had about my work during the department seminars. Next, I would like to express my gratitude to my thesis committee formed by Prof.
    [Show full text]
  • Functional Characterization of Prenyltransferases Involved in the Biosynthesis of Polycyclic Polyprenylated Acylphloroglucinols in the Genus Hypericum
    Functional characterization of prenyltransferases involved in the biosynthesis of polycyclic polyprenylated acylphloroglucinols in the genus Hypericum Von der Fakultät für Lebenswissenschaften der Technischen Universität Carolo-Wilhelmina zu Braunschweig zur Erlangung des Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) genehmigte D i s s e r t a t i o n von Mohamed Mamdouh Sayed Nagia aus Kalyobiya/ Ägypten 1. Referent: Professor Dr. Ludger Beerhues 2. Referent: Professor Dr. Alain Tissier eingereicht am: 30.07.2018 mündliche Prüfung (Disputation) am: 15.10.2018 Druckjahr 2018 „Gedruckt mit Unterstützung des Deutschen Akademischen Austauschdienstes“ „Und sag: O mein Herr, mehre mein Wissen“ Der Edle Qur’an [20: 114] Vorveröffentlichungen der Dissertation Teilergebnisse aus dieser Arbeit wurden mit Genehmigung der Fakultät für Lebenswissenschaften, vertreten durch den Mentor der Arbeit, in folgenden Beiträgen vorab veröffentlicht: Publikationen Nagia, M., Gaid, M., Biedermann, E., Fiesel, T., El-Awaad, I., Haensch, R., Wittstock, U., and Beerhues, L. Sequential regiospecific gem-diprenylation of tetrahydroxyxanthone by prenyltransferases from Hypericum sp. (Submitted). Nagia, M., Gaid, M., Beuerle, T., and Beerhues, L. Successive xanthone prenylation in Hypericum sampsonii. Planta Medica International Open 4, Tu-SL-01 (2017). doi: 10.1055/s-0037-1608308 Tagungsbeiträge A. Vorträge Nagia M., Gaid M., Biedermann E., Beuerle T., Beerhues L., Successive xanthone prenylation in Hypericum sampsonii, 65th Annual Meeting of the Society for Medicinal Plant and Natural Product Research, Basel, Switzerland, 3. – 7. September 2017. Nagia M., Gaid M., Behrends S., Beerhues L., Novel PPAP-related prenyltransferases, 4. SynFoBiA -Kolloquium des Pharmaverfahrenstechnik (PVZ), Braunschweig, Germany, 26. February 2016. Nagia M., Gaid M., Beurele T., Biedermann E., Beerhues L., Aromatic Prenyltransferases from Hypericum sampsonii, Postgraduate workshop of the section „Natural Products“ German Society for Plant Sciences (DBG), Meisdorf, Germany , 11.
    [Show full text]